SandBox: Difference between revisions

	Pulmonary Embolism Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pulmonary Embolism from other Diseases
Epidemiology and Demographics
Risk Factors
Triggers
Natural History, Complications and Prognosis
Diagnosis
Diagnostic criteria
Assessment of Clinical Probability and Risk Scores
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores
History and Symptoms
Physical Examination
Laboratory Findings
Arterial Blood Gas Analysis
D-dimer
Biomarkers
Electrocardiogram
Chest X Ray
Ventilation/Perfusion Scan
Echocardiography
Compression Ultrasonography
CT
MRI
Treatment
Treatment approach
Medical Therapy
IVC Filter
Pulmonary Embolectomy
Pulmonary Thromboendarterectomy
Discharge Care and Long Term Treatment
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Follow-Up
Support group
Special Scenario
Pregnancy
Cancer
Trials
Landmark Trials
Case Studies
Case #1
SandBox On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on SandBox
CDC on SandBox
SandBox in the news
Blogs on SandBox
Directions to Hospitals Treating SandBox
Risk calculators and risk factors for SandBox

VisualWikitext

Revision as of 19:53, 4 November 2011

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editors-in-Chief: Ujjwal Rastogi, MBBS [2]

Overview

Pulmonary embolism (PE) is a potentially lethal condition, with a mortality rate close to 30 percent without treatment. Thus prompt and effective therapy is utmost important. In most cases, anticoagulant therapy is the mainstay of treatment. Acutely, supportive treatments, such as oxygen or analgesia, are often required.

Treatment Algorithm

Stabilize the patient

Is anticoagulation contraindicated ?

Yes

No

Diagnostic evaluation

Anticoagulate with SC LMWH or IV UFH

PE excluded

PE confirmed

Diagnostic evaluation

No further Treatment

Inferior vena cava filter

PE excluded

PE confirmed

Discontinue Anticoagulants

Clinicaly severe enough to need Thrombolysis

Yes

No

Is thrombolytic Contraindicated?

Continue Anticoagulants

Yes

No

Surgical emblectomy or catheter based interventions

Hold Anticoagulation, Give Thrombolytics then resume Anticoagulations

Patient show Clinically Improvement

No

Yes

Surgical emblectomy or catheter based interventions

Continue Anticoagulation

Template:WH Template:WS

@@ Line 1: / Line 1: @@
-You can do just about anything here - please try out the features.
+{{Pulmonary embolism}}
+{{CMG}}
+'''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]
+==Overview==
+'''Pulmonary embolism''' (PE) is a potentially lethal condition, with a mortality rate close to 30 percent without treatment. Thus prompt and effective therapy is utmost important. In most cases, [[anticoagulant]] therapy is the mainstay of treatment. Acutely, supportive treatments, such as [[oxygen]] or [[analgesia]], are often required.
-{{filepath|LeftHeart.jpg|view this image}}
+==Treatment Algorithm==
+{{familytree/start |summary=PE treatment Algorithm.}}
+{{familytree | | | | | | | | GMa | GMa='''Stabilize the patient'''}}
+{{familytree | | | | | | | | |!| }}
+{{familytree | | | | | | | | GPa | GPa='''Is [[anticoagulation]] contraindicated ?'''}}
+{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }}
+{{familytree | | |JOE| | | | | | | |SIS| | | JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}}
+{{familytree | | | |!| | | | | | | | | |!| }}
+{{familytree | | |MOM| | | | | | | | SIS | | |MOM=[[Pulmonary embolism diagnosis|'''Diagnostic evaluation''']]|SIS=Anticoagulate with SC [[LMWH]] or IV [[Heparin|UFH]]}}
+{{familytree | |,|-|^|.| | | | | | | | |!| }}
+{{familytree |GPa| |JOE| | | | | |A01|GPa=PE excluded|JOE='''PE confirmed'''|A01=[[Pulmonary embolism diagnosis|'''Diagnostic evaluation''']]}}
+{{familytree | |!| | | |!| | | | | |,|-|^|.| }}
+{{familytree |C01| |C02| | |C03| |C04|C01=No further Treatment|C02='''[[Inferior vena cava filter#Pulmonary embolism inferior vena cava filter|Inferior vena cava filter]]'''|C03=PE excluded|C04='''PE confirmed'''}}
+{{familytree | | | | | | | | | | |!| | | |!|}}
+{{familytree | | | | | | | | | |SIS| |B02|SIS='''Discontinue Anticoagulants'''|B02='''Clinicaly severe enough to need [[Thrombolysis]]'''}}
+{{familytree | | | | | | | | | | | | |,|-|^|-|.| }}
+{{familytree | | | | | | | | | | | |JOE| |SIS|JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}}
+{{familytree | | | | | | | | | | | | |!| | | |!| }}
+{{familytree | | | | | | | | | | | |SIS| |B02|SIS='''Is [[thrombolytic]] Contraindicated?'''|B02=Continue Anticoagulants}}
+{{familytree | | | | | | | | | | |,|-|^|-|.| }}
+{{familytree | | | | | | | | |JOE| |SIS|JOE='''Yes'''|ME=Inconclusive study|SIS='''No'''}}
+{{familytree | | | | | | | | | | |!| | | |!| }}
+{{familytree | | | | | | | | | |SIS| |B02|SIS='''[[Pulmonary thrombectomy|Surgical emblectomy]]''' or '''[[Pulmonary embolism catheter based interventions|catheter based interventions]]'''|B02='''Hold Anticoagulation, Give Thrombolytics then resume Anticoagulations'''}}
+{{familytree | | | | | | | | | | | | | | |!| | | |}}
+{{familytree | | | | | | | | | | | | | |SIS|SIS=Patient show Clinically Improvement}}
+{{familytree | | | | | | | | | | | | |,|-|^|-|.| }}
+{{familytree | | | | | | | | | | | |JOE| |SIS|JOE='''No'''|ME=Inconclusive study|SIS='''Yes'''}}
+{{familytree | | | | | | | | | | | | |!| | | |!| }}
+{{familytree | | | | | | | | | | | |SIS| |B02|SIS='''[[Pulmonary thrombectomy|Surgical emblectomy]]''' or '''[[Pulmonary embolism catheter based interventions|catheter based interventions]]'''|B02=Continue Anticoagulation}}
+{{familytree/end}}
-==New section==
+[[Category:Hematology]]
+[[Category:Pulmonology]]
-===subsection===
+[[Category:Cardiology]]
+[[Category:Emergency medicine]]
-new line starts a paragraph
+{{WH}}
-new line starts a paragraph
+{{WS}}
-breaking lines <br> without breaking a paragraph
-creating a list
-*indications for:
-**number one
-***number two
-****number three
-end of list
-*new list:
-; definition list: heart block
-how to make a horizontal line
-----
-like this?
-create a Wiki link like this: [[Wiki link]]
-bullets
-* like
-* this
-  * but they won't indent
-headings:
-= text of heading 1 =
-== text of heading 2 ==
-will build your table of contents:
-__TOC__
-A numbered list:
-# this is the first thing
-# this is next
-## a subheading
-This is how to add tabs:
-:u1
-::u2
-:::u3
-:erhghrj
-::jsdnvds
-:::kasnc
-<poll>
-test poll1
-answer1
-answer2
-answer3
-answer4
-</poll>
-[[Category:Help]]
-[[image:Graph_of_Early-Onset_Disease_Incidence.jpg|thumb]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}
-PROVA <ref name="pmid21060709">{{cite journal |author=Tannous G, Neff G, Kemmer N |title=Therapeutic Success of Rifaximin for Clostridium difficile Infection Refractory to Metronidazole and Vancomycin |journal=Case Rep Gastroenterol |volume=4 |issue=3 |pages=404–409 |year=2010 |pmid=21060709 |pmc=2975008 |doi=10.1159/000320685 |url=}}</ref>

SandBox: Difference between revisions

Revision as of 19:53, 4 November 2011

Overview

Treatment Algorithm

Navigation menu